INS and glucose metabolism disease: Compared with naïve C57BL/6J mice, SELENOF KO mice showed the differential expression of hepatic proteins involved in the glucose metabolic pathways, glucose intolerance and insulin reduction, suggesting that glucose metabolism disorders were induced by SELENOF KO [22,23].